Key Notes
- OpenAI has reportedly cut its fundraising target from $30 billion to about $20 billion as some investors reduce their allocations.
- The $1.25 trillion valuation was already reported in October, while the Journal now puts commitments so far at roughly $11 billion.
- Anthropic has filed for a proposed Nasdaq IPO, but its final offering price and first trading date remain unconfirmed.
OpenAI has reduced the target for its latest funding round by $10 billion to about $20 billion, with a reported valuation of $1.25 trillion, as a technology-stock selloff tests investor appetite for the AI industry’s enormous capital requirements.
The Financial Times reported the revised goal, citing people familiar with the matter. A separate Wall Street Journal report put commitments secured so far at approximately $11 billion and said OpenAI expected to raise more in the coming weeks.
The reports describe a financing still taking shape. They also place OpenAI’s fundraising alongside rival Anthropic’s proposed Nasdaq IPO, creating two major tests of how investors price frontier AI businesses and their future spending.
Funding Goal Falls by One-Third
Moving from $30 billion to $20 billion reduces the amount sought by one-third. The Journal’s approximately $11 billion commitment figure is equivalent to 55% of the revised target and roughly 37% of the original goal.
Reuters, relaying the FT report, said OpenAI had set an October 30 deadline for commitments. The initial closing was expected to fall short of $20 billion after some investors reduced their allocations.
The FT identified a UAE investor consortium including MGX as the expected largest participant. It also reported that OpenAI would receive an option to lease newly developed computing capacity in the region as part of the arrangement.
Commitments, completed investment and cash available to spend are different measures. The reported $11 billion does not establish that every dollar has already reached OpenAI’s bank accounts or that the round cannot grow further.
The Valuation Reset Predates the Latest Cut
The $1.25 trillion valuation is approximately $150 billion, or 10.7%, below the earlier $1.4 trillion negotiating target. However, that lower figure was already public before this latest reduction in the fundraising goal.
CNBC reported on October 22 that OpenAI was seeking up to $30 billion at a $1.25 trillion pre-money valuation. We previously covered those discussions and the role of UAE investors and Coatue at the time.
The funding goal has now fallen even as the valuation remains at the level reported last week. That sequence shows the pressure on the financing’s size as well as its price.
There is also a distinction between lowering a proposed price and completing a down round. OpenAI’s March 31 announcement said it had closed a financing with $122 billion in committed capital at an $852 billion post-money valuation.
March’s valuation includes that round’s capital, whereas CNBC described the newer target before new investment. Final terms and comparable valuation definitions are necessary to assess the financing precisely.
AI Spending Raises the Financing Stakes
The funding effort arrives as investors reassess the scale and economics of AI infrastructure investment. The Nasdaq Composite fell about 2.9% on Friday, Reuters reported, extending pressure on the technology companies against which private AI businesses are often compared.
We reported the wider October 30 selloff across stocks, precious metals and cryptocurrency. A change in the prices investors will pay for public technology companies can influence the terms private businesses seek, although the two markets operate differently.
CNBC’s earlier funding report said OpenAI had told investors in February that it targeted approximately $600 billion of computing spending through 2030. That was a prospective spending figure, rather than money already spent.
For a company planning infrastructure commitments over several years, the relevant questions include how much financing is secured, when it becomes available and how customer revenue develops alongside those obligations. A smaller round changes the financing plan without, by itself, proving that the underlying business has stopped growing.
Anthropic’s IPO Creates Another Test
Anthropic confirmed on October 26 that it filed a public S-1 registration statement and intended to list Class A shares on the Nasdaq Global Select Market under the proposed symbol ANT. Its announcement left the share count and offering price range undetermined.
Earlier International Financing Review reporting called for a November 9 roadshow and pricing the following week, with a potential $2 trillion valuation. That remains a reported target, rather than a confirmed first trading date or final IPO price.
As we previously explained, the key questions include the proposed offering terms, Anthropic’s financial disclosures and what prospective ANT shareholders would own. A public filing moves the process forward but does not complete a stock-market debut.
OpenAI is pursuing a 2027 listing, according to Reuters and CNBC’s earlier reporting. That timetable was already in circulation before the latest funding news; the reduction does not establish a newly announced IPO postponement.
Pre-IPO Contracts Reflect a Separate Market
Crypto-exchange products linked to OpenAI and Anthropic provide another sentiment signal, but their prices are not completed private financing valuations. OKX’s documentation describes its pre-IPO products as cash-settled derivatives that confer no shares, IPO allocation or shareholder rights.
The exchange says prices are market-driven and may diverge materially from private funding rounds or eventual IPO prices. Contract design, liquidity and the share-count assumptions used by a venue affect the comparison.
An exchange contract can consequently move while the company’s most recently agreed private financing price remains unchanged. Conversely, a new funding agreement does not force every derivatives venue to trade at that exact valuation.
The next concrete milestones are OpenAI’s confirmed closing amount and terms, followed by any updated Anthropic price range or listing timetable. Those disclosures will provide firmer benchmarks for investors than fundraising targets or synthetic pre-IPO prices alone.
